ThromboGenics Announces That the FDA Intends to Grant Ocriplasmin Priority Review - Healthy Lifestyle Community

Member Login:

If this is your first visit, be sure to check out the FAQ by clicking the link above. You may have to register before you can post: click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below.

Press and Publicity About A Healthy Lifestyle Company and Organization Press and Publicity from around the world about maintaining a Healthy Lifestyle. If you would like to post a press release to this section, please contact a site moderator.

Display Modes

Search this Thread

Thread Tools

02-02-2012, 05:44 AM	#1
Healthy Lifestyle Master Status: Administrator Join Date: Sep 2009 Posts: 22,952 Rep Power: 10	ThromboGenics Announces That the FDA Intends to Grant Ocriplasmin Priority Review LEUVEN, Belgium, February 2, 2012 /PRNewswire/ -- Company to Re-Submit Ocriplasmin BLA to Meet Priority Review Timelines ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the FDA intended to... More... __________________ Focus On A Healthy Lifestyle

Bookmarks

« Pass Kidney Stones Safely with New Thermobalancing Therapy States Fine... | Some Men Get Tongue-Tied with Women »

Thread Tools	Search this Thread
Show Printable Version Email this Page	Search this Thread: Advanced Search
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is On Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

Currently Active Users: 20 (1 members and 19 guests)
Threads: 25,529, Posts: 28,895, Members: 21,661
Welcome to our newest members, szvtxdvzz.

Latest Threads

Hottest Threads

Most Viewed Threads